Federal Circuit Affirms Invalidity Judgment Concerning AXIRON® (Testosterone) Transdermal Solution -
RMMS Partner William Rakoczy Recognized by Chambers & Partners -
RMMS Scores Win in Europe Relating to Shire’s Factor VIII ADVATE Franchise -
RMMS Named “U.S. Firm to Watch” by Managing Intellectual Property Magazine -
Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution) -
RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL) -